Asthma and COPD Drugs Market - Top Companies and Manufacturers

Companies dominating the Asthma and COPD Drugs Landscape

GlaxoSmithKline plc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
AstraZeneca
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd.
Novartis AG
Sanofi
CHIESI Farmaceutici S.p.A.
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Abbott

Browse Key Market Insights with Data Illustration:

Asthma and COPD Drugs Market Size, Forecast Report 2037

In the News

Dignity Health, and Propeller Health announced that they have integrated Propeller’s platform into Dignity Health’s electronic health record (EHR) system, which is fully implemented in seven communities served by Dignity Health physicians and clinics in Arizona and California.
True Corporation along with partners, Easy Asthma & COPD Clinics (EACC), a network of respiratory disease treatment clinics, and GlaxoSmithKline Thailand (GSK), a researcher and developer of innovative drugs and vaccines, launched “Telehealth Together” project to take care of patients suffering from respiratory diseases using True's health intelligent healthcare platform for telehealth services.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of asthma and COPD drugs is evaluated at USD 43.03 billion.

The asthma and COPD drugs market size was over USD 40.5 billion in 2024 and is anticipated to exceed USD 105.44 billion by the end of 2037, witnessing over 7.7% CAGR during the forecast period i.e., between 2025-2037. High prevalence and incidence of asthma and COPD, decreasing environmental air quality, and the presence of harmful gases and particles will boost the market growth.

North American industry will hold the largest share by 2037, as growing healthcare infrastructure in the region is able to provide the required treatment to the patients.

The major players in the market include GlaxoSmithKline plc., AstraZeneca, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi, CHIESI Farmaceutici S.p.A., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Abbott.

Asthma and COPD Drugs Market - Top Companies and Manufacturers

Companies dominating the Asthma and COPD Drugs Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the asthma and COPD drugs market?

What are the factors driving the asthma and COPD drugs landscape?

Which region held the largest asthma and COPD drugs industry share?

Who are the key players in the asthma and COPD drugs sector?